Author of the publication

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group

, , , , , , , , , , , , , , , , , , , , , , , , and . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 (12): 3810–3821 (1998)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group, , , , , , , , , and 15 other author(s). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, (1998)Clonality and life cycles of intestinal crypts explained by a state dependent stochastic model of epithelial stem cell organization, , , , and . Journal of theoretical biology, 186 (1): 41–54 (1997)A model of the control of cellular regeneration in the intestinal crypt after perturbation based solely on local stem cell regulation, , and . Cell proliferation, 25 (6): 559–578 (1992)The differentiation and lineage development of goblet cells in the murine small intestinal crypt: experimental and modelling studies, , , , and . Journal of cell science, (1993)Scoring mitotic activity in longitudinal sections of crypts of the small intestine, , , , and . Cell and tissue kinetics, 21 (4): 231–246 (1988)Modell- und evidenzbasierte Planung klinischer Studien beim Hodgkin-Lymphom, , , , and . Der Onkologe, 6 (12): 1197–1201 (2000)Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5, , , , , , , , , and 16 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 (2): 476–484 (2002)The crypt cycle in mouse small intestinal epithelium, , , , and . Journal of Cell Science, 107 (12): 3271–3279 (1994)Are patients with Hodgkin lymphoma and high-grade non-Hodgkin lymphoma in clinical therapy optimization protocols representative of these groups of patients in Germany?, , , , , and . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 21 (10): 2045–2051 (2010)BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group, , , , , , , , , and 15 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 (12): 3810–3821 (1998)